EBOS GROUP LIMITED — Director's Dealing 2022

Sep 6, 2022

==> picture [98 x 35] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		6-Sep-22
Date of last disclosure:		31-Jan-22
Director or senior manager giving disclosure
Full name(s):		John Cullity
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief Executive Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:		Ordinaryshares
Nature of the affected relevant interest(s):		Issue of shares pursuant to performance
		rightsplan
For that relevant interest-
Number held in class before acquisition or disposal:		1,458 ordinaryshares
Number held in class after acquisition or disposal:		24,186 ordinaryshares
Current registered holder(s):		N/A
Registeredholder(s) once transfers areregistered:		John Cullity

To NZX Limited; and	To NZX Limited; and	To NZX Limited; and
Name of listed issuer:				EBOS GroupLimited
Date this disclosure made:				6-Sep-22
Date of last disclosure:				31-Jan-22
Director or senior manager giving disclosure
Full name(s):				John Cullity
Name of listed issuer:				EBOS GroupLimited
Name of related body corporate (if applicable):				N/A
Position held in listed issuer:				Chief Executive Officer
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)Class ofaffected quotedfinancialproducts:Nature of the affected relevant interest(s):For that relevant interest-
Class ofaffected quotedfinancialproducts:				Ordinaryshares
Nature of the affected relevant interest(s):				Issue of shares pursuant to performancerightsplan
For that relevant interest-
Number held in class before acquisition or disposal:				1,458 ordinaryshares
Number held in class after acquisition or disposal:				24,186 ordinaryshares
Current registered holder(s):				N/A
Registeredholder(s) once transfers areregistered:				John Cullity
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab				le)
Type of affected derivative:
Class of underlyingfinancialproducts:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any):
A statement as to whether the derivative is cash settled orphysicallysettled:
Maturitydate of the derivative(if any):
Expirydate of the derivative(if any):
Theprice specified in the terms of the derivative(if any):
	in the terms of the derivative(if any):
Any other details nunder the derivativeunderlyingfinancial	eeded to understand how the amount of the consideth l f th diti i fftd b th l	ration payablef th
	or e vaue o e ervave s aece y e va products:	e o e
_For that derivative,- _
Parties to the deriv	ative:
If the director or seinterestinthe deriv	ior manaer is not a art to the derivative the nat	ure of the relevant
	g py ,ative:
Details of transact	ions giving rise to acquisition or disposal
Total numberoftra
	nsactions towhich noticerelates:			1
Details of transact	ions requiring disclosure-
Date oftransaction:				1-Sep-22
Nature of transaction:				Issue of shares pursuant to performancerightsplan
Name ofany otherparty orparties to the transaction(if known):				N/A
The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value,describe the consideration:				Nil
Numberof financialproducts towhichthe transaction related:				22,728 ordinaryshares
If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:				No

Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod:		N/A	N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal:
Class ofquotedfinancialproducts:
Nature of relevant interest:
_For that relevant interest,- _
Number heldinclass:
Currentregisteredholder(s):
For a derivative relevant interest,-
Type ofderivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of theunderlyingfinancialproducts:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative:
Certification		6-Sep-22Janelle Cain, General Counsel, EBOS GroupLimited
I certify that, to the best of my knowledge and belief, the information contained in thisdisclosure is correct and that I am duly authorised to make this disclosure by all personsfor whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:

==> picture [98 x 35] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		6-Sep-22
Date of last disclosure:		31-Jan-22
Director or senior manager giving disclosure
Full name(s):		Brett Barons
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		CEO,Symbion
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)Class ofaffected quotedfinancialproducts:Nature of the affected relevant interest(s):For that relevant interest-
Class ofaffected quotedfinancialproducts:		Ordinaryshares
Nature of the affected relevant interest(s):		Issue of shares pursuant to performancerightsplan
For that relevant interest-
Number held in class before acquisition or disposal:		1,458 ordinaryshares
Number held in class after acquisition or disposal:		11,686 ordinaryshares
Current registered holder(s):		N/A
Registered holder(s) once transfers are registered:		Brett Barons
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab		le)
Type of affected derivative:
Class of underlyingfinancialproducts:
Details of affected derivative-
The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any):
A statement as to whether the derivative is cash settled orphysicallysettled:
Maturitydate of the derivative(if any):
Expirydate of the derivative(if any):
Theprice specified in the terms of the derivative(if any):
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of theunderlyingfinancialproducts:
_For that derivative,- _
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevantinterestinthe derivative:
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		1-Sep-22
		Issue of shares pursuant to performancerightsplan
		N/A
		Nil
		10,228 ordinaryshares
		No

Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod:	Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod:	Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod:		N/A	N/A
Date of t	heprior written clearance(if any):			N/A
Summar	y of other relevant interests after acquisition or disposal:
Class of	quotedfinancialproducts:			Ordinaryshares
Nature o	f relevant interest:			1. Registered holder - 2016 long termincentive plan2. Registered holder - 2017 long termincentiveplan
_For that _	_relevant interest,- _			1. 55,000 ordinary shares2. 55,000 ordinarysharesBrett Barons
Number	heldinclass:
Currentr	egisteredholder(s):
For a de	rivative relevant interest,-
Type ofderivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any):
	( any):
A statem	ent as to whether the derivative is cash settled or physically settled:
Maturity	date of the derivative (if any):
Expiry da
	te of the derivative (if any):
The pric	e's specified terms (if any):
Any otheunder thunderlyin	r details needed to understand how the amount of the consideration payabderivative or the value of the derivative is affected b the value of the	le
	ygfinancialproducts:
For that
	erivative relevant interest,-
Parties t	o the derivative:
If the dirinterest i	ector or senior manager is not a party to the derivative, the nature of the reln the derivative:	evant
Certifica	tion
I certify tdisclosurfor whom	hat, to the best of my knowledge and belief, the information contained in the is correct and that I am duly authorised to make this disclosure by all perit is made.	issons
Signatur	e of director or officer:
Date of s	ignature:
or
Signatur	e of person authorised to sign on behalf of director or officer:
Date of s	ignature:			6-Sep-22
Name an	d title of authorised person:			Janelle Cain, General Counsel, EBOS GroupLimited

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer:		EBOS GroupLimited
Date this disclosure made:		6-Sep-22
Date of last disclosure:		15-Oct-20
Director or senior managergiving disclosure
Full name(s):		LeonardHansen
Name of listed issuer:		EBOS GroupLimited
Name of related body corporate (if applicable):		N/A
Position held in listed issuer:		Chief FinancialOfficer

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products:		Ordinary shares
Nature of the affected relevant interest(s):		Issue of shares pursuant toperformance rightsplan
For that relevant interest-
Number held in class before acquisition or disposal:		327
Number held in class after acquisition or disposal:		1,472
Current registered holder(s):		N/A
Registered holder(s) once transfers are registered:		Leonard Hansen

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

		le)
		N/A
		N/A
The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any):		N/A
A statement as to whether the derivative is cash settled orphysicallysettled:		N/A
Maturitydate of the derivative(if any):		N/A
Expirydate of the derivative(if any):		N/A
Theprice specified in the terms of the derivative(if any):		N/A
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of theunderlying financial products:		N/A
_For that derivative,- _Parties to the derivative:If the director or senior manager is not a party to the derivative, the nature of the relevantinterestinthe derivative:
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevantinterestinthe derivative:		N/A
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates:		1
		1-Sep-22
		Issue of shares pursuant toperformance rightsplan
		N/A

The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value,describe the consideration:		Nil	Nil
Numberof financialproducts towhichthe transaction related:		1,145 ordinary shares
If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details—
Whether relevantinterestswere acquired ordisposed ofduring a closed period:		No
Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod:		N/A
Date of theprior written clearance(if any):		N/A
Summary of other relevant interests after acquisition or disposal:Class ofquotedfinancialproducts:Nature of relevantinterest:_For that relevant interest,- _Number heldinclass:Currentregisteredholder(s):For a derivative relevant interest,-Type ofderivative:Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any):		N/A
A statement as to whether the derivative is cash settled or physically settled:		N/A
Maturity date of the derivative (if any):		N/A
Expiry date of the derivative (if any):		N/A
The price's specified terms (if any):		N/A
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of theunderlyingfinancialproducts:		N/A
For that derivative relevant interest,-
Parties to the derivative:		N/A
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative:		N/A

Certification

Certification
I certify that, to the best of my knowledge and belief, the information contained in thisdisclosure is correct and that I am duly authorised to make this disclosure by all personsfor whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:		6-Sep-22
Name and title of authorised person:		Janelle Cain, General Counsel,EBOS Group Limited